Selegiline Absorption: Empty vs. Full Stomach
Selegiline bioavailability is increased 3 to 4-fold when taken with food, but this does not translate to a clinical requirement for food administration—the drug can be taken without regard to meals for Parkinson's disease treatment. 1
Key Pharmacokinetic Evidence
The FDA drug label provides definitive guidance on selegiline's food interaction:
- Food increases bioavailability by 3-4 fold when comparing fed to fasted states 1
- Peak plasma concentrations (Cmax) increase approximately 3-fold with food 2
- Time to maximum concentration is delayed from 2.75 hours (fasting) to 4.0 hours (fed) 2
- The absolute bioavailability of oral selegiline is only approximately 10% due to extensive first-pass metabolism 3
Clinical Implications and Dosing Recommendations
Despite the pharmacokinetic food effect, the FDA-approved dosing regimen does not specify administration relative to meals. The standard dosing is 5 mg twice daily (at breakfast and lunch), which inherently involves taking the medication with food 1. This suggests that:
- The increased bioavailability with food was accounted for in the clinical trial dosing that established efficacy
- The drug can be taken consistently with meals without safety concerns
- No adjustment for empty stomach administration is required or recommended
Important Mechanistic Considerations
The food effect on selegiline is consistent with highly extracted compounds where absorption or metabolism is site-specific 2. The prolonged gastric residence time with food likely contributes to increased absorption despite the drug's lipophilicity and limited aqueous solubility.
Critical distinction: While food increases systemic exposure to selegiline itself, metabolite levels (N-desmethylselegiline, L-amphetamine, and L-methamphetamine) remain largely unaffected by food 2. Since selegiline's therapeutic effect involves irreversible MAO-B inhibition rather than direct plasma concentration-effect relationships, the clinical significance of the food effect is limited.
Practical Recommendation
Administer selegiline 5 mg twice daily at breakfast and lunch (with food) as per FDA labeling. 1 There is no clinical advantage to empty stomach administration, and the increased bioavailability with food does not necessitate dose adjustment. Consistency in administration (always with or always without food) is more important than the specific prandial state chosen.
The contrast with other medications is notable—unlike levothyroxine 4 or certain oral iron preparations 5 where empty stomach administration significantly improves therapeutic outcomes, selegiline's dosing was established with food intake and does not require fasting administration.